MSP Recovery, Inc. reports that its Class A common stock and publicly traded warrants will be moved by OTC Markets Group from the OTC Pink Limited Information tier to the Expert Market on or around July 17, 2026. This change follows the company’s failure to file its Form 10-K for the period ending December 31, 2025 and Form 10-Q for the period ending March 31, 2026, leaving it non-current under SEC reporting rules and Rule 15c2-11 requirements for public quoting. On the Expert Market, broker-dealers may publish only unsolicited quotes, and quotations are primarily accessible to broker-dealers, institutions, and other sophisticated investors, which can significantly limit retail trading access and liquidity.
MSP Recovery, Inc. supplements its August 5, 2022 prospectus to register resale and warrant-related securities, listing up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants, and up to 236,019 shares issuable upon exercise of warrants.
The company also filed a Current Report disclosing a one-time Hazel Letter Agreement advance of $0.2 million funded June 26, 2026, under the discretionary Operational Collection Floor of its Working Capital Credit Facility. The prospectus notes a prior 1-for-7 reverse stock split effective September 1, 2025, and provides June 29, 2026 closing market prices for common stock and warrants.
MSP Recovery, Inc. files a prospectus supplement registering 285,715 shares of Class A Common Stock for offer and sale by the selling securityholder under its Form S-1 registration.
The supplement updates the prospectus with a Current Report on June 30, 2026 and describes the Yorkville SEPA, under which the company may issue and sell shares to YA II PN, Ltd. up to an aggregate contractual capacity of $250,000,000 (subject to ownership and exchange caps). The Yorkville arrangements include convertible notes and multiple amendments that set conversion mechanics, pricing floors, and historical Floor Price adjustments. The supplement notes that sales by Yorkville are resale transactions for which the company will not receive proceeds when Yorkville sells its shares; proceeds treatment for company-issued sales under the SEPA is described separately in the prospectus.
MSP Recovery, Inc. filed a Prospectus Supplement No. 63 updating its resale prospectus to cover the offer and sale of up to 32,220 shares of Class A Common Stock, including up to 15,239 shares issuable upon exercise of the CPIA Warrant at an exercise price of $0.4375 per share. The supplement attaches a Form 8-K describing a one-time $0.2 million advance from Hazel Partners Holdings, LLC under the Company’s discretionary Working Capital Credit Facility. The supplement notes closing market prices as of June 29, 2026 and that share counts reflect a 1-for-7 reverse stock split effective September 1, 2025.
MSP Recovery, Inc. amends its October 4, 2024 prospectus to register for resale 56,896 shares of Class A Common Stock. The supplement incorporates a Current Report on Form 8-K disclosing a one-time $0.2 million advance from Hazel Partners under the Company’s working capital facility and other selling‑holder details.
The registered shares include warrants issuable to Virage affiliates and shares issued to Palantir; the VRM and VRP warrants have a $0.0175 per‑share exercise price. Share and per‑share amounts reflect a 1-for-7 reverse stock split effective September 1, 2025.
MSP Recovery, Inc. entered a material letter agreement with Hazel Partners Holdings LLC, its lender under an existing working capital credit facility, for a one-time advance of $0.2 million on June 26, 2026. The funding is to be used primarily for operating expenses and was provided under Hazel’s discretionary “Operational Collection Floor” mechanism.
The company previously disclosed aggregate advances of about $6.0 million under this mechanism, with no remaining capacity. This new advance temporarily increases that floor but is described as a standalone accommodation that does not reinstate or reopen availability under the facility. MSP Recovery states that aside from this specific amount, no additional funding is available, and it has no rights to or reasonable basis to expect further advances from Hazel.
The company emphasizes that the $0.2 million advance does not change the discretionary nature of the credit facility or provide ongoing or recurring liquidity, and cautions that it should not be viewed as evidence of future funding or the company’s ability to meet operating or debt service obligations beyond this limited support.
MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock for resale by selling securityholders and to register up to 755,200,000 warrants and up to 236,019 shares issuable upon exercise of warrants.
The supplement gives effect to a 1-for-7 reverse stock split effective September 1, 2025 and discloses market closing prices on June 17, 2026. Separately, the company received a $0.1 million one‑time discretionary advance from Hazel Partners Holdings LLC under its working capital credit facility; aggregate prior advances under that discretionary mechanism had reached $6.0 million.
MSP Recovery, Inc. filed Prospectus Supplement No. 64 registering 285,715 shares of Class A Common Stock for resale by YA II PN, Ltd. (Yorkville) under a Standby Equity Purchase Agreement (Yorkville SEPA). The SEPA contemplates up to $250 million of purchases subject to a 9.99% Ownership Limitation and earlier Exchange Cap mechanics. The supplement updates prior terms and attaches a Form 8-K describing a separate $0.1 million discretionary advance from Hazel Partners under the working capital facility. The prospectus states the Company will not receive proceeds from resales by Yorkville, while sales the Company elects to make to Yorkville under the SEPA could generate proceeds to the Company.
MSP Recovery, Inc. files a prospectus supplement registering 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a warrant (the CPIA Warrant). The CPIA Warrant exercise price is $0.4375 per share, so exercise would produce only nominal proceeds to the company.
The supplement attaches a Form 8-K disclosing a one-time $0.1 million discretionary advance from Hazel Partners Holdings LLC under the company’s working capital credit facility and notes that the facility remains discretionary with no committed availability. The company effected a 1-for-7 reverse stock split effective September 1, 2025.
MSP Recovery, Inc. files Prospectus Supplement No. 51 to register 56,896 shares of Class A Common Stock for resale by selling securityholders, including warrants exercisable into shares and shares issued for services. The supplement reflects a 1-for-7 reverse stock split effective September 1, 2025.
The prospectus lists (i) up to 28,572 shares issuable on exercise of VRM Warrants, (ii) 2,858 shares issued to VRP plus up to 14,286 shares issuable on a VRP Warrant, and (iii) 11,180 shares issued to Palantir. Exercise price for VRM and VRP warrants is $0.0175 per share. The supplement attaches the Company’s Form 8-K disclosing a one-time $0.1 million advance from Hazel under a discretionary working capital mechanism; prior advances under that mechanism totaled approximately $6.0 million.